Semmelweis Symposium 2015: Molecular Oncology: from bench to bedside

Larus Conference Center, Budapest

In association with Federation of Hungarian Medical Associations

5th NOVEMBER, 2015

9.00-9.15 Opening Ceremony

Morning Session: Experimental cancer research
Chair person: Hunyady L

9.15-9.30 Nagy P. 1st Institute of Pathology and Experimental Cancer Research, SU: Imatinib preserves the functional organization and amends regeneration of liver in CDE fed mice

9.30-9.45 Kovalszky I. 1st Institute of Pathology and Experimental Cancer Research, SU: Tumorstroma interaction of hepatomas with slow and fast proliferation rates.

9.45-10.05 Ligeti E. Department of Physiology, SU: Role of Rac/Rho GTPase activating proteins in regulation of cellular functions

10.05-10.20 Döme B. Department of Thoracic Surgery, SU: Tumor vascularization

10.20-10.35 Tímár J, Rásó E.. 2nd Department of Pathology, SU: IFN resistance of melanoma

10.35-10.55 Kéri Gy. HAS-SU Pathobiochemistry Research Unit: In vitro combination therapy based on driver genes

10.55-11.10 Coffee break

11.10-11.25 Enyedi A. HAS-SU Molecular Oncology Research Unit: Ca++ signaling in BRAF mutant melanoma

11.25-11.45 Albini A, Fondazio MultiMedica, Milan: Angiogenesis and tumor microenvironment as tergets for cancer prevention

11.45-12.00 Noonan D. University of Insubria, Varese: Immune cell polarization in cancer

12.00-12.30 Jalkanen S. Biocity Turku: New tools to target lymphatics in cancer spread

12.30-14.00 Lunch break, poster viewing

Afternoon Session: Cancer genomics
Chairpersons: Kosztolányi Gy, Mandl J

14.00-14.30 Dietel M. Charité, Berlin: Molecular pathology in XXIst century

14.30-15.00 Patócs A. HAS-SU Lendület program: Endocrine cancers

15.00-15.30 Szállási Z. HAS-SU Molecular Oncology Research Unit: Opening new avenues for cancer treatment by next generation sequencing

15.30-16.00 Coffee break

16.00-16.15 Bödör Cs HAS-SU Ledület program: Identification of novel therapeutic targets in follicular lymphoma using NGS

16.15-16.30 Győrffy B, HAS-SU Lendület program: Computing offtarget-effect by cross-analysis of transcriptome-level data from 1,118 studies

16.30-16.50, Bock C, CeMM Research Center, Vienna, Epigenomics and single-cell sequencing in cancer and beyond

16.50-17.10 Marko-Varga Gy, University of Lund: Threading protein expressions into disease surveillance strategy within modern healthcare

17.10-17.30 Jalkanen M, Pharon Pharmeceuticals: SME as a central link between the bench and the bedside

17.30- poster viewing

19.00: Dinner and Cultural Evening at Semmelweis Salon: Jazz and wine
(main building, Semmelweis University Campus)

6th NOVEMBER 2015

Morning Session: Molecular Pathology of Cancer
Chairperson: Olah E.

9.00-9.20 Matolcsy A. 1st Institute of Pathology and Experimental Cancer Research, SU: Molecular diagnostics of lymphomas

9.20-9.40 Kiss A. 2nd Department of Pathology, SU: Predictive markers of Sorafenib sensitivity of HCC

9.40-10.00 Lakatos P. 1st Department of Ínternal Medicine, SU: Molecular pathology of thyroid cancers

10.00-10.20 Sápi Z. 1st Institute of Pathology and Experimental Cancer Research, SU: Molecular alterations of diagnostic value: eptheloid and synovial sarcomas

10.20-10.40. Szász AM, 2nd Department of Pathology: Gene expression based novel prognostic factors in breast cancer

10.40-11.00 Coffee break

11.00-11.20 Hegedűs B. Department of Thoracic Surgery, Medical University of Vienna: Oncogenic mutations of the EGFR pathway in lung adenocarcinoma

11.20-11.50 Hoefler G, Department of Pathology, Graz: Genetic heterogeneity of colorectal cancer

11.50-12.00 Poster award – Experimental

12.00-12.10 Poster Award – Translational

12.10-14.00 Lunch Break

Afternoon Session: Molecular Oncology in Clinic
Chairperson: Tulassay Zs

14.00-14.15 Demeter J, 1st Department of Internal Medicine, SU: Experience with targeted therapy in chronic myeloid leukemia and hairy cell leukemia

14.15-14.30 Dank M. Department of Oncology, SU: AVAREG study

14.30-14.45 Igaz P. 2nd Department of Internal Medicine, SU: MicroRNAs and genomics in adrenal tumors

14.45-15.00 Coffee break

15.00-15.30 Schmoll HJ, Martin-Luther University Halle-Wittenberg, Current standards and new targets in colorectal cancer

15.30-16.00 Immunooncology TBA

16.00-16.30 Talor E, CelSci, USA: Multikine a novel approach to cancer immunotherapy

16.30-16.45 Closing remarks